Facilitated communication

Facilitated communication (FC) is a controversial technique used to assist individuals with severe communication disabilities. The method involves a facilitator who supports the hand or arm of the individual while they type on a keyboard or point to letters on a communication board. Proponents claim that FC allows individuals with autism and other communication disorders to express themselves, while critics argue that the facilitator may unconsciously influence the messages being produced.
History[edit]
Facilitated communication was first developed in the 1970s by Rosemary Crossley in Australia. It gained popularity in the United States in the late 1980s and early 1990s, largely due to the work of Douglas Biklen, a professor at Syracuse University. Biklen and others believed that FC could unlock the potential of individuals with severe communication impairments, particularly those with autism.
Methodology[edit]
In facilitated communication, the facilitator provides physical support to the communicator, typically by holding their hand, wrist, or arm. The facilitator may also provide verbal encouragement and emotional support. The goal is to help the individual focus and overcome motor difficulties that may impede their ability to communicate independently.
Criticism and Controversy[edit]

Facilitated communication has been the subject of significant controversy. Critics argue that the technique lacks scientific validity and that messages produced through FC are often influenced by the facilitator rather than the individual. Numerous studies have demonstrated that facilitators can unknowingly guide the communication, leading to false or misleading messages.
In some cases, facilitated communication has led to serious consequences, such as false allegations of abuse. As a result, many professional organizations, including the American Psychological Association and the American Speech-Language-Hearing Association, have issued statements against the use of FC.
Current Use and Alternatives[edit]
Despite the controversy, some practitioners and families continue to use facilitated communication, believing it to be beneficial for certain individuals. However, there is a growing emphasis on evidence-based practices and alternative communication methods, such as augmentative and alternative communication (AAC) devices, which do not rely on a facilitator.
Related Pages[edit]
| Communication |
|---|
| General aspects |
| Fields |
| Disciplines |
| Categories |
| Autism | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
